This is the authors' abstract. We don't add key points for this paper.
Background: Considering low efficacy, and high toxicity of the commonly used drugs in cryptosporidiosis,in addition to the development of drug resistance, trial for a novel approach is required.Objective: To evaluate the efficacy of Nifuroxazide (Antinal), Trimethoprim-Sulfamethoxazole (Septrin),Nitazoxanide (NTZ), loaded-on copper-benzene tricarboxylate (Cu-BTC) metal organic frameworks(MOH) for treatment of Cryptosporidium-experimentally infected mice.Material and Methods: Ninety male Swiss albino mice were divided into nine groups. Except for the 1stgroup (control negative), all mice were infected with 103 Cryptosporidium oocysts. Except for 2nd group < br />(infected non treated), the remaining groups of infected mice were administered the tested drugs 2ndday post infection (PI) for 7 days. Daily stool examination for oocyst shedding from day 3 to 18 PI wasconducted to evaluate drugs’ efficacy. Furthermore, to confirm Cryptosporidium complete eradication, realtime PCR (RT-PCR) was performed on stool samples collected after 3 weeks PI. Survival rate was alsocalculated for 3 weeks PI (at 7th, 14th and 21st d) to detect drugs’ efficacy. Besides, physical characterizationand toxicity of Cu-BTC were performed before mice treatment.Results: Electron micrographs revealed 300-500 nm pyramidal crystals of Cu-BTC. Non-loaded Antinal,Septrin, and NTZ showed 67.2%, 62.2% and 76.6% reduction in oocyst shedding, while loaded drugsshowed 88.4%, 66.7%, and 98.3% reduction, respectively. Additionally, RT-PCR revealed that the besttreatment for cryptosporidiosis was NTZ@Cu-BTC, followed by antinal@Cu-BTC. Interestingly, using Cu-BTC alone had a relative positive therapeutic effect. Concerning the survival rate, Cu-BTC alone had 90%total survival that increased to100% when Cu-BTC was incorporated with studied drugs in all treatedgroups.Conclusion: The results indicated that Cu-BTC is an efficient delivery system that improved the efficacyof the commonly used drugs.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
SOLIMAN et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: